<DOC>
	<DOCNO>NCT01990469</DOCNO>
	<brief_summary>After screen , 2-week , single-blind placebo run-in , 174 patient randomize 1 : 1 ratio addition either once-daily Gemigliptin 50 mg placebo ongoing stable dos glimepiride combination metformin 24 week .</brief_summary>
	<brief_title>Efficacy Safety Gemigliptin 50mg qd Added Patients With Type 2 Diabetes Inadequately Controlled Glimepiride Metformin</brief_title>
	<detailed_description>Subjects visit center Week 6 , 12 , 18 24 entire 24-week treatment period . Total study duration approximately 26weeks subject practice exercise/diet control together .</detailed_description>
	<criteria>1 . Patients Type 2 Diabetes Mellitus 2 . Adults age â‰¥ 19 year old 3 . Patients HbA1c 7 % ~11 % Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
</DOC>